Zynerba Pharmaceuticals, Inc. Equity-NMS: ZYNE

$1.3 0 (April 1, 2025)

Healthcare

Drug Manufacturers - Specialty & Generic

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$1.3
5Y :-66.6%

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Zynerba Pharmaceuticals, Inc. today?

Zynerba Pharmaceuticals, Inc. (ZYNE) share price as of April 1, 2025, is $1.3. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Zynerba Pharmaceuticals, Inc.?

Yes, Indian Investors can invest in the Zynerba Pharmaceuticals, Inc. (ZYNE) Share by opening an international trading account with Angel One.

How can I purchase Zynerba Pharmaceuticals, Inc. shares in India?

Purchasing Zynerba Pharmaceuticals, Inc. (ZYNE) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Zynerba Pharmaceuticals, Inc. (ZYNE) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Zynerba Pharmaceuticals, Inc.?

Yes, you can purchase fractional shares of Zynerba Pharmaceuticals, Inc. (ZYNE) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Zynerba Pharmaceuticals, Inc.?

The market capitalization of Zynerba Pharmaceuticals, Inc. on April 1, 2025, is $0.

In which sector Zynerba Pharmaceuticals, Inc. belongs?

Zynerba Pharmaceuticals, Inc. operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.

What documents are required to invest in Zynerba Pharmaceuticals, Inc. stocks?

In order to invest in Zynerba Pharmaceuticals, Inc. (ZYNE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders. The Company is engaged in improving the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome (FXS), and chromosome 22q11.2 deletion syndrome (22q). It is focused on using cannabinoids for treating behavioral symptoms of FXS and 22q. It is developing Zygel (ZYN002), a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol (THC). It uses a patent protected formulation containing ethanol and propylene glycol as solubilizing agents and Transcutol HP as a permeation enhancer. Zygel is an investigational drug product in development for the potential treatment of behavioral symptoms associated with FXS, 22q, and autism spectrum disorder (ASD).